Business
Guardant Health’s Shield Blood Test for Colorectal Cancer Screening Now Available for U.S. Military Members and Families
PALO ALTO, Calif., January 08, 2026--Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced its Shield blood test for colorectal cancer screening (CRC) is now covered for active-duty service members and their families through TRICARE, the U.S. military’s health insurance coverage, with no copay for average-risk individuals ages 45 and older.
About this update from Guardant Health, Inc.
[{"type":"image","alt":"","displaySize":"","headline":null,"caption":"","credit":null,"className":"","disableSlideshowImg":false,"size":{"original":{"width":1806,"height":619,"url":"https://media.zenfs.com/en/business-wire.com/c303c56551dad7b29721defb5545adc5"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/.pxLOeeLa2ncSXXCTQCUzg--/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MDtoPTMyOTtjZj13ZWJw/https://media.zenfs.com/en/business-wire.com/c303c56551dad7b29721defb5545adc5","width":960,"height":329},"lightbox":{"url":"https://s.yimg.com/ny/api/res/1.2/VFOu5BUHGt5W0jCB7HeUZQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTI0MDA7aD04MjI7Y2Y9d2VicA--/https://media.zenfs.com/en/business-wire.com/c303c56551dad7b29721defb5545adc5","width":1200,"height":411}},"lazy":false},{"type":"list","items":[{"val":[{"type":"text","content":"Active-duty service members and eligible family members now have access to blood test for colorectal cancer screening with no copay","length":131,"tagName":"p","attribs":{}}]}],"tagName":"ul","bulletedList":true,"length":131,"olType":false},{"type":"text","content":"PALO ALTO, Calif., January 08, 2026--(BUSINESS WIRE)--Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced its Shield blood test for colorectal cancer screening (CRC) is now covered for active-duty service members and their families through TRICARE, the U.S. military’s health insurance coverage, with no copay for average-risk individuals ages 45 and older.","length":395,"tagName":"p"},{"type":"text","content":"Shield is the first and only blood test approved by the FDA as a primary screening option for CRC, offering U.S. military troops a more pleasant and convenient option for screening by overcoming barriers associated with other screening methods. According to the Department of Defense, there are approximately 1.3 million active-duty service members. Those above the age of 45 – along with their families of screening-eligible age – will now have access to Shield, the latest innovation in CRC screening.","length":503,"tagName":"p"},{"type":"text","content":""Continuing to expand coverage for Shield across the U.S. from our nation’s veterans to our active-duty service members will help provide greater access to Shield’s life-saving screening benefit from just a blood draw," said AmirAli Talasaz, Guardant Health co-CEO. "TRICARE has a long history of bring...